← Open Payments lookup

JAIME GIRON: Open Payments

NPI 1346321197 · SOLEDAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$894 in 37 payments from 8 companies in 2025. Trend: 2023 $2,161 · 2024 $1,333 · 2025 $894

Food & beverage: $894
CompanyPaymentsAmount
Lilly USA, LLC12$304
Novo Nordisk Inc12$260
Boehringer Ingelheim Pharmaceuticals, Inc.1$116
PFIZER INC.4$65
Dexcom, Inc.3$60
ABBVIE INC.2$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$33
Bayer Healthcare Pharmaceuticals Inc.1$17

Products named: JARDIANCE, Rybelsus, Ozempic, PREVNAR 20, Dexcom G6 Transmitter, QULIPTA, XIFAXAN, Wegovy.

Industry payments across CA — which companies pay providers there.